After a traumatic event, injured workers may want to avoid the scene of the accident. But returning to work could help them heal.
Benzodiazepines (BZDs) are frequently prescribed for anxiety, insomnia, and muscle spasms—conditions that often follow workplace injuries or motor vehicle accidents. But prolonged BZD use can disrupt recovery and delay return to function. That’s why careful, proactive management is essential.
In workers’ comp, not all injuries are visible. Case managers play a critical role in spotting hidden mental health challenges like anxiety, depression, and trauma that can delay recovery.
Nicole Usher discusses solutions to staffing shortages in home health and diagnostic services in her WCI-TV interview at the WCI Conference.
In this WCI-TV interview, Kim Radcliffe explains how direct access to PT helps injured employees recover faster, with fewer missed workdays and lower costs.
Mitchell today announced the release of its latest Plugged-In: EV Collision Insights report. The Q2 2025 edition examines the decrease in collision claims frequency for repairable battery electric vehicles (BEVs) in the U.S. and increase in mild hybrid electric vehicle (MHEV) claims across North America. It also explores how changes to government incentive programs are impacting consumer adoption of BEVs on both sides of the border.
Claims frequency for repairable, collision-damaged battery electric vehicles (BEVs) fell for the first time in the U.S.—dropping to 2.92% last quarter, a decrease of 7%. This decline coincided with a 6.3% reduction in new BEV purchases compared to Q2 2024 despite record-breaking sales earlier in the year. Consumer demand is being tested as federal tax incentives are set to expire in September while discounts for electrified options reached an all-time high of nearly $8,500 per automobile by the end of the quarter.